title: HIV-1 superinfection occurs less frequently than initial infection in a cohort of high-risk Kenyan women.
abstract: HIV superinfection (reinfection) has been reported in several settings, but no study has been designed and powered to rigorously compare its incidence to that of initial infection. Determining whether HIV infection reduces the risk of superinfection is critical to understanding whether an immune response to natural HIV infection is protective. This study compares the incidence of initial infection and superinfection in a prospective seroincident cohort of high-risk women in Mombasa, Kenya. A next-generation sequencing-based pipeline was developed to screen 129 women for superinfection. Longitudinal plasma samples at <6 months, >2 years and one intervening time after initial HIV infection were analyzed. Amplicons in three genome regions were sequenced and a median of 901 sequences obtained per gene per timepoint. Phylogenetic evidence of polyphyly, confirmed by pairwise distance analysis, defined superinfection. Superinfection timing was determined by sequencing virus from intervening timepoints. These data were combined with published data from 17 additional women in the same cohort, totaling 146 women screened. Twenty-one cases of superinfection were identified for an estimated incidence rate of 2.61 per 100 person-years (pys). The incidence rate of initial infection among 1910 women in the same cohort was 5.75 per 100 pys. Andersen-Gill proportional hazards models were used to compare incidences, adjusting for covariates known to influence HIV susceptibility in this cohort. Superinfection incidence was significantly lower than initial infection incidence, with a hazard ratio of 0.47 (CI 0.29-0.75, p = 0.0019). This lower incidence of superinfection was only observed >6 months after initial infection. This is the first adequately powered study to report that HIV infection reduces the risk of reinfection, raising the possibility that immune responses to natural infection are partially protective. The observation that superinfection risk changes with time implies a window of protection that coincides with the maturation of HIV-specific immunity.
authors.affiliation: Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
authors.forename: Keshet
authors.initials: K
authors.lastname: Ronen
authors.forename: Connor O
authors.initials: CO
authors.lastname: McCoy
authors.forename: Frederick A
authors.initials: FA
authors.lastname: Matsen
authors.forename: David F
authors.initials: DF
authors.lastname: Boyd
authors.forename: Sandra
authors.initials: S
authors.lastname: Emery
authors.forename: Katherine
authors.initials: K
authors.lastname: Odem-Davis
authors.forename: Walter
authors.initials: W
authors.lastname: Jaoko
authors.forename: Kishor
authors.initials: K
authors.lastname: Mandaliya
authors.forename: R Scott
authors.initials: RS
authors.lastname: McClelland
authors.forename: Barbra A
authors.initials: BA
authors.lastname: Richardson
authors.forename: Julie
authors.initials: J
authors.lastname: Overbaugh
mesh_terms: D000328:Adult; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000453:epidemiology* / Q000235:genetics / Q000276:immunology*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D006801:Humans; D015994:Incidence; D007630:Kenya / Q000453:epidemiology; D015163:Superinfection / Q000453:epidemiology* / Q000235:genetics / Q000276:immunology*; D013997:Time Factors